4//SEC Filing
Precision Onco Ltd 4
Accession 0000899243-18-020445
CIK 0001434418other
Filed
Jul 22, 8:00 PM ET
Accepted
Jul 23, 8:02 PM ET
Size
7.4 KB
Accession
0000899243-18-020445
Insider Transaction Report
Form 4
Precision Onco Ltd
10% Owner
Transactions
- Conversion
Series F Preferred Stock
2018-07-23−3,500,000→ 0 total→ Common Stock (317,921 underlying) - Conversion
Common Stock
2018-07-23+317,921→ 317,921 total
Footnotes (1)
- [F1]On July 23, 2018, the Series F Preferred Stock converted into Common Stock on a 11.009-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series F Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date.
Documents
Issuer
CONSTELLATION PHARMACEUTICALS INC
CIK 0001434418
Entity typeother
IncorporatedVirgin Islands, British
Related Parties
1- filerCIK 0001746718
Filing Metadata
- Form type
- 4
- Filed
- Jul 22, 8:00 PM ET
- Accepted
- Jul 23, 8:02 PM ET
- Size
- 7.4 KB